METHODS OF TREATING HER2-POSITIVE LOCALLY ADVANCED OR PREVIOUSLY UNTREATED METASTATIC BREAST CANCER

摘要

Methods of treating patients having HER2-positive, locally advanced or previously untreated metastatic breast cancer having received prior treatment with a taxane using an anti-HER2-maytansinoid conjugate (for example trastuzumab emtansine) are provided.